Publication | Closed Access

Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice

InflammationMetabolic SyndromeCardiovascular DiseaseMedicineMyocardial InfarctionDiabetesPhysiologyCardiovascular PharmacologyCardiologyEmpagliflozin PreventsCardiovascular ToxicityPharmacologyAtherosclerosisNon-diabetic MiceAcute Myocardial InfarctionHealth Sciences